Sfoglia per Rivista KIDNEY INTERNATIONAL
A method for monitoring vascular access function during hemodialysis
2009 Ciandrini A; Lodi CA; Galato R; Miscia MC; Fattori MS; Cavalcanti S.
Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.
2004 Pescucci C; Mari F; Longo I; Vogiatzi P; Caselli R; Scala E; Abaterusso C; Gusmano R; Seri M; Miglietti N; Bresin E; Renieri A
Corrigendum to “Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D and Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.” Kidney Int. 2020;97:1287–1296 (Kidney International (2020) 97(6) (1287–1296), (S0085253820301526), (10.1016/j.kint.2020.01.035))
2021 Rondeau E.; Scully M.; Ariceta G.; Barbour T.; Cataland S.; Heyne N.; Miyakawa Y.; Ortiz S.; Swenson E.; Vallee M.; Yoon S.-S.; Kavanagh D.; Haller H.; Babu S.; Broeders N.; Lietar N.; Brown F.; Campbell P.; Campistol J.M.; Blasco M.; Chowdhury P.; Kasimatis T.; Cirami L.; Caroti L.; Antognoli G.; Delmas Y.; Dobronravov V.; Gaeckler A.; Garrouste C.; Greenwood G.; Griffin S.; Huang C.-C.; Chen I.-R.; Huang S.; Kim J.S.; La Manna G.; Comai G.; Cappuccilli M.; Le Quintrec M.; Jeantet G.; Fumie I.; Luque Y.; Menne J.; Morelle J.; Goffin E.; Muhlfeld A.; Nagaraj S.; Arepally G.; Oh D.; Okumi M.; Terente M.P.; Gutierrez E.; Rodriguez P.; Provot F.; Schonermarck U.; Fischereder M.; Terrada N.R.; Seitz-Polski B.; Favre G.; Boyer-Suavet S.; Vinogradova M.; Kirsanova T.; Wong E.K.S.
Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe
2018 Brück, Katharina*; Jager, Kitty J.; Zoccali, Carmine; Bello, Aminu K.; Minutolo, Roberto; Ioannou, Kyriakos; Verbeke, Francis; Völzke, Henry; Arnlöv, Johan; Leonardis, Daniela; Ferraro, Pietro Manuel; Brenner, Hermann; Caplin, Ben; Kalra, Philip A.; Wanner, Christoph; Castelao, Alberto Martinez; Gorriz, Jose Luis; Hallan, Stein; Rothenbacher, Dietrich; Gibertoni, Dino; De Nicola, Luca; Heinze, Georg; Van Biesen, Wim; Stel, Vianda S.
Erratum to “Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D, Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment” Kidney Int. 2020;97:1287–1296 (Kidney International (2020) 97(6) (1287–1296), (S0085253820301526), (10.1016/j.kint.2020.01.035))
2020 Rondeau E.; Scully M.; Ariceta G.; Barbour T.; Cataland S.; Heyne N.; Miyakawa Y.; Ortiz S.; Swenson E.; Vallee M.; Yoon S.-S.; Kavanagh D.; Haller H.; Babu S.; Broeders N.; Lietar N.; Brown F.; Campbell P.; Chowdhury P.; Kasimatis T.; Cirami L.; Caroti L.; Antognoli G.; Delmas Y.; Dobronravov V.; Gaeckler A.; Garrouste C.; Greenwood G.; Griffin S.; Huang C.-C.; Chen I.-R.; Huang S.; Kim J.S.; La Manna G.; Comai G.; Cappuccilli M.; Le Quintrec M.; Jeantet G.; Fumie I.; Luque Y.; Menne J.; Morelle J.; Goffin E.; Muhlfeld A.; Nagaraj S.; Arepally G.; Oh D.; Okumi M.; Terente M.P.; Gutierrez E.; Rodriguez P.; Provot F.; Schonermarck U.; Fischereder M.; Terrada N.R.; Seitz-Polski B.; Favre G.; Boyer-Suavet S.; Vinogradova M.; Kirsanova T.; Wong E.K.S.
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes
2020 Zivna M.; Kidd K.; Zaidan M.; Vyletal P.; Baresova V.; Hodanova K.; Sovova J.; Hartmannova H.; Votruba M.; Treslova H.; Jedlickova I.; Sikora J.; Hulkova H.; Robins V.; Hnizda A.; Zivny J.; Papagregoriou G.; Mesnard L.; Beck B.B.; Wenzel A.; Tory K.; Haeffner K.; Wolf M.T.F.; Bleyer M.E.; Sayer J.A.; Ong A.C.M.; Balogh L.; Jakubowska A.; Laszkiewicz A.; Clissold R.; Shaw-Smith C.; Munshi R.; Haws R.M.; Izzi C.; Capelli I.; Santostefano M.; Graziano C.; Scolari F.; Sussman A.; Trachtman H.; Decramer S.; Matignon M.; Grimbert P.; Shoemaker L.R.; Stavrou C.; Abdelwahed M.; Belghith N.; Sinclair M.; Claes K.; Kopel T.; Moe S.; Deltas C.; Knebelmann B.; Rampoldi L.; Kmoch S.; Bleyer A.J.
Model-based study of the effects of the hemodialysis technique on the compensatory response to hypovolemia
2004 CAVALCANTI S.; A. CIANDRINI; S. SEVERI; F. BADIALI; S. BINI; A. GATTIANI; L. CAGNOLI; A. SANTORO
Muscle IGF-I levels in hemodialysis patients
2005 Lemmey, A.B.; Macdonald, J.H.; Marcora, S.M.; Jibani, M.
Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring
2021 Waldman M.; Soler M.J.; Garcia-Carro C.; Lightstone L.; Turner-Stokes T.; Griffith M.; Torras J.; Valenzuela L.M.; Bestard O.; Geddes C.; Flossmann O.; Budge K.L.; Cantarelli C.; Fiaccadori E.; Delsante M.; Morales E.; Gutierrez E.; Nino-Cruz J.A.; Martinez-Rueda A.J.; Comai G.; Bini C.; La Manna G.; Slon M.F.; Manrique J.; Agraz I.; Sinaii N.; Cravedi P.
T-cell exhaustion correlates with improved outcomes in kidney transplant recipients
2019 Fribourg, Miguel; Anderson, Lisa; Fischman, Clara; Cantarelli, Chiara; Perin, Laura; La Manna, Gaetano; Rahman, Adeeb; Burrell, Bryna E.; Heeger, Peter S.; Cravedi, Paolo*
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A method for monitoring vascular access function during hemodialysis | Ciandrini A; Lodi CA; Galato R; Miscia MC; Fattori MS; Cavalcanti S. | 2009-01-01 | KIDNEY INTERNATIONAL | - | 1.01 Articolo in rivista | - |
| Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. | Pescucci C; Mari F; Longo I; Vogiatzi P; Caselli R; Scala E; Abaterusso C; Gusmano R; Seri M; Mig...lietti N; Bresin E; Renieri A | 2004-01-01 | KIDNEY INTERNATIONAL | - | 1.01 Articolo in rivista | - |
| Corrigendum to “Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D and Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.” Kidney Int. 2020;97:1287–1296 (Kidney International (2020) 97(6) (1287–1296), (S0085253820301526), (10.1016/j.kint.2020.01.035)) | Rondeau E.; Scully M.; Ariceta G.; Barbour T.; Cataland S.; Heyne N.; Miyakawa Y.; Ortiz S.; Swen...son E.; Vallee M.; Yoon S.-S.; Kavanagh D.; Haller H.; Babu S.; Broeders N.; Lietar N.; Brown F.; Campbell P.; Campistol J.M.; Blasco M.; Chowdhury P.; Kasimatis T.; Cirami L.; Caroti L.; Antognoli G.; Delmas Y.; Dobronravov V.; Gaeckler A.; Garrouste C.; Greenwood G.; Griffin S.; Huang C.-C.; Chen I.-R.; Huang S.; Kim J.S.; La Manna G.; Comai G.; Cappuccilli M.; Le Quintrec M.; Jeantet G.; Fumie I.; Luque Y.; Menne J.; Morelle J.; Goffin E.; Muhlfeld A.; Nagaraj S.; Arepally G.; Oh D.; Okumi M.; Terente M.P.; Gutierrez E.; Rodriguez P.; Provot F.; Schonermarck U.; Fischereder M.; Terrada N.R.; Seitz-Polski B.; Favre G.; Boyer-Suavet S.; Vinogradova M.; Kirsanova T.; Wong E.K.S. | 2021-01-01 | KIDNEY INTERNATIONAL | - | 1.04 Replica / breve intervento (e simili) | - |
| Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe | Brück, Katharina*; Jager, Kitty J.; Zoccali, Carmine; Bello, Aminu K.; Minutolo, Roberto; Ioannou..., Kyriakos; Verbeke, Francis; Völzke, Henry; Arnlöv, Johan; Leonardis, Daniela; Ferraro, Pietro Manuel; Brenner, Hermann; Caplin, Ben; Kalra, Philip A.; Wanner, Christoph; Castelao, Alberto Martinez; Gorriz, Jose Luis; Hallan, Stein; Rothenbacher, Dietrich; Gibertoni, Dino; De Nicola, Luca; Heinze, Georg; Van Biesen, Wim; Stel, Vianda S. | 2018-01-01 | KIDNEY INTERNATIONAL | - | 1.01 Articolo in rivista | - |
| Erratum to “Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D, Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment” Kidney Int. 2020;97:1287–1296 (Kidney International (2020) 97(6) (1287–1296), (S0085253820301526), (10.1016/j.kint.2020.01.035)) | Rondeau E.; Scully M.; Ariceta G.; Barbour T.; Cataland S.; Heyne N.; Miyakawa Y.; Ortiz S.; Swen...son E.; Vallee M.; Yoon S.-S.; Kavanagh D.; Haller H.; Babu S.; Broeders N.; Lietar N.; Brown F.; Campbell P.; Chowdhury P.; Kasimatis T.; Cirami L.; Caroti L.; Antognoli G.; Delmas Y.; Dobronravov V.; Gaeckler A.; Garrouste C.; Greenwood G.; Griffin S.; Huang C.-C.; Chen I.-R.; Huang S.; Kim J.S.; La Manna G.; Comai G.; Cappuccilli M.; Le Quintrec M.; Jeantet G.; Fumie I.; Luque Y.; Menne J.; Morelle J.; Goffin E.; Muhlfeld A.; Nagaraj S.; Arepally G.; Oh D.; Okumi M.; Terente M.P.; Gutierrez E.; Rodriguez P.; Provot F.; Schonermarck U.; Fischereder M.; Terrada N.R.; Seitz-Polski B.; Favre G.; Boyer-Suavet S.; Vinogradova M.; Kirsanova T.; Wong E.K.S. | 2020-01-01 | KIDNEY INTERNATIONAL | - | 1.04 Replica / breve intervento (e simili) | - |
| An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes | Zivna M.; Kidd K.; Zaidan M.; Vyletal P.; Baresova V.; Hodanova K.; Sovova J.; Hartmannova H.; Vo...truba M.; Treslova H.; Jedlickova I.; Sikora J.; Hulkova H.; Robins V.; Hnizda A.; Zivny J.; Papagregoriou G.; Mesnard L.; Beck B.B.; Wenzel A.; Tory K.; Haeffner K.; Wolf M.T.F.; Bleyer M.E.; Sayer J.A.; Ong A.C.M.; Balogh L.; Jakubowska A.; Laszkiewicz A.; Clissold R.; Shaw-Smith C.; Munshi R.; Haws R.M.; Izzi C.; Capelli I.; Santostefano M.; Graziano C.; Scolari F.; Sussman A.; Trachtman H.; Decramer S.; Matignon M.; Grimbert P.; Shoemaker L.R.; Stavrou C.; Abdelwahed M.; Belghith N.; Sinclair M.; Claes K.; Kopel T.; Moe S.; Deltas C.; Knebelmann B.; Rampoldi L.; Kmoch S.; Bleyer A.J. | 2020-01-01 | KIDNEY INTERNATIONAL | - | 1.01 Articolo in rivista | REN_FULL_14AUG2020-2-65.pdf |
| Model-based study of the effects of the hemodialysis technique on the compensatory response to hypovolemia | CAVALCANTI S.; A. CIANDRINI; S. SEVERI; F. BADIALI; S. BINI; A. GATTIANI; L. CAGNOLI; A. SANTORO | 2004-01-01 | KIDNEY INTERNATIONAL | - | 1.01 Articolo in rivista | - |
| Muscle IGF-I levels in hemodialysis patients | Lemmey, A.B.; Macdonald, J.H.; Marcora, S.M.; Jibani, M. | 2005-01-01 | KIDNEY INTERNATIONAL | - | 1.04 Replica / breve intervento (e simili) | - |
| Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring | Waldman M.; Soler M.J.; Garcia-Carro C.; Lightstone L.; Turner-Stokes T.; Griffith M.; Torras J.;... Valenzuela L.M.; Bestard O.; Geddes C.; Flossmann O.; Budge K.L.; Cantarelli C.; Fiaccadori E.; Delsante M.; Morales E.; Gutierrez E.; Nino-Cruz J.A.; Martinez-Rueda A.J.; Comai G.; Bini C.; La Manna G.; Slon M.F.; Manrique J.; Agraz I.; Sinaii N.; Cravedi P. | 2021-01-01 | KIDNEY INTERNATIONAL | - | 1.01 Articolo in rivista | - |
| T-cell exhaustion correlates with improved outcomes in kidney transplant recipients | Fribourg, Miguel; Anderson, Lisa; Fischman, Clara; Cantarelli, Chiara; Perin, Laura; La Manna, Ga...etano; Rahman, Adeeb; Burrell, Bryna E.; Heeger, Peter S.; Cravedi, Paolo* | 2019-01-01 | KIDNEY INTERNATIONAL | - | 1.01 Articolo in rivista | nihms-1522724.pdf |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile